Skip to main content
Premium Trial:

Request an Annual Quote

Babraham Institute Launches New Facility

NEW YORK (GenomeWeb News) – The Babraham Institute in Cambridge, UK, opened a new £22 million ($36 million) biomedical research facility this week.

The Biological Support Unit was built with £17 million in funding support and was outfitted with £5 million worth of equipment, including funds from the Biotechnology and Biological Sciences Research Council.

"This state-of-the-art facility will be vital, increasing the likelihood of scientific breakthroughs whilst ensuring the highest standards of animal welfare," Science and Innovation Minister Lord Paul Drayson said in a statement.

Babraham said that the BSU building was built with high-tech automation and robotics incorporated into its design.

Research programs at Babraham include epigenetics and cell signaling studies on aging, cancer, heart failure, autoimmune diseases, hypertension, and other medical challenges.

"The new facility will enable our scientists to remain at the forefront of globally-competitive biomedical research and enhance bioscience in our region," Babraham Director Michael Wakelam said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.